Unicycive Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| UNCY | QURE | CTNM | HRTX | CHRS | DMAC | |
|---|---|---|---|---|---|---|
| Market cap | 102.72M | 1.60B | 368.31M | 56.69M | 131.36M | 580.78M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 2.6 | -7.8 | -5.0 | -2.7 | -1.3 | -14.4 |
| Price/book | 2.0 | 7.2 | 1.6 | 9.6 | 2.2 | 15.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −21.62% | −8.40% | −11.08% | −74.77% | −42.95% | +50.38% |
| Today | +4.46% | −3.52% | +1.03% | +4.88% | +5.54% | +7.70% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All UNCY news ›Unicycive Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Join Premium — 33% OFF: $9.99 (was $14.99) Monthly Research Reports · Ad-free browsing · 30-day money back guarantee Mountain View, California – Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a biotechnology…
United Parcel Service Appoints Reckitt CFO Shannon Eisenhardt to Board
marketscreener.com United Parcel Service, Inc. Air Freight & Logistics United Parcel Service Appoints Reckitt CFO Shannon Eisenhardt to Board Published on 11/04/2026 at 07:13 pm EST Latest news about United Parcel Service, Inc
Catalent Appoints Wetteny Joseph as Pharma and Consumer Health President
Former Catalent executive and current Zoetis CFO Wetteny Joseph returns to lead the CDMO's Pharma and Consumer Health segment. Catalent has appointed Wetteny Joseph as Group President, Pharma and Consumer Health (PCH), effective…
Unicycive Therapeutics: 95% Upside Priced Against A Wall Of Dilution And Regulatory Risk
Unicycive Therapeutics is rated Buy, with a risk-adjusted fair value of $6.97 per share, nearly 95% upside from current prices. Read more on UNCY stock here. - Unicycive Therapeutics is rated Buy, with a risk-adjusted fair value of $6.97…
Calidi Biotherapeutics, Inc. Announces Appointment of Corsee Sanders to Board of Directors and Member of the Audit Committee, Effective June 17, 2026
Calidi Biotherapeutics, Inc. announced the appointment of Corazon Sanders, Ph.D., to the Board of Directors, effective June 17, 2026 with a term expiring at the Company?s 2029 annual meeting of... announced the appointment of Corazon…
What's Next for Unicycive Therapeutics, Inc. Shareholders After 39.1% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
Oct 23, 2026, 14:10 ET Complaint alleges Unicycive Therapeutics, Inc. misled investors between December 29, 2025 and June 29, 2026; investors may seek lead plaintiff role by November 2, 2026 Investors who suffered losses on Unicycive…
Unicycive Deadline: UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, Oct. 24, 2026 /PRNewswire/ -- 24, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities ofà Unicycive Therapeutics, Inc (NASDAQ: UNCY) between December 29, 2025 and June 29,…
UNCY UPCOMING DEADLINE: SueWallSt Alerts Unicycive Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
Oct 22, 2026, 10:11 ET A securities class action alleges Unicycive Therapeutics never inspected or audited its third-party manufacturer's facility for cGMP compliance before resubmitting the OLC New Drug Application, exposing shareholders…
Unicycive Therapeutics (NASDAQ:UNCY) Stock Price Down 1.3% – Here’s What Happened
Posted by Kim Johansen on Oct 24th, 2026 Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Get Free Report)’s stock price traded down 1.3% on Friday. The stock traded as low as $3.71 and last traded at $3.89. Approximately 1,212,401 shares…
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027
This page contains content provided by third parties, including sponsored or paid material. Pinion Newswire has not independently reviewed, verified, or endors
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- globenewswire.com21
- newsfilecorp.com10
- prnewswire.com10
- marketscreener.com3
- tradingview.com3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 69 articles, not a forecast.